Published in J Hum Hypertens on June 01, 2001
Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrol Dial Transplant (2010) 1.28
Arteriosclerotic renal artery stenosis: conservative versus interventional management. Heart (2002) 0.85
Statins and renovascular disease in the elderly: a population-based cohort study. Eur Heart J (2010) 0.82
Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis. J Am Soc Hypertens (2015) 0.77
British Hypertension Society guidelines for hypertension management 1999: summary. BMJ (1999) 8.80
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens (2008) 6.82
Survey of use of anticoagulation in patients with atrial fibrillation. BMJ (1993) 5.71
Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens (2002) 4.93
Double-blind randomised trial of modest salt restriction in older people. Lancet (1997) 3.96
Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev (2004) 3.90
Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens (2007) 3.20
Renal artery stenosis masquerading as congestive heart failure. Lancet (1993) 3.10
Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet (1982) 3.07
Sarcoidosis, thyroiditis, and Addison's disease. Lancet (1970) 2.84
Distal venous arterialisation for salvage of critically ischaemic inoperable limbs. Lancet (1999) 2.64
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Salt--more adverse effects. Lancet (1996) 2.17
Is "idiopathic" edema idiopathic? Lancet (1979) 2.11
The use of the angio-seal haemostatic puncture closure device in high risk patients. Clin Radiol (1999) 2.08
Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int (1980) 2.01
Diuretic-induced oedema. Lancet (1975) 1.84
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.84
Moderate potassium supplementation in essential hypertension. Lancet (1982) 1.83
Percutaneous transluminal angioplasty by a retrograde subintimal transpopliteal approach. Clin Radiol (1994) 1.82
Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens (1996) 1.81
Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta (1978) 1.77
The measurement of angiotensin-converting enzyme in subjects receiving captopril. N Engl J Med (1980) 1.72
Familial Guillain-Barré syndrome. Lancet (1965) 1.71
Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol (2010) 1.66
Transbrachial arteriography: indications and complications. Clin Radiol (1996) 1.62
Fortnightly review: Beneficial effects of potassium. BMJ (2001) 1.59
Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens (2003) 1.59
Platelet volume is not increased in essential hypertension. J Hum Hypertens (1994) 1.48
Mineralocorticoid deficiency in HIV infection. BMJ (1989) 1.43
Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature (1981) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion. Circulation (1996) 1.41
Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens (1991) 1.39
A review of alternative approaches in the management of iatrogenic femoral pseudoaneurysms. Ann R Coll Surg Engl (1999) 1.38
Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet (1985) 1.38
Investigating progressive unexplained renal impairment and hypertension. BMJ (2007) 1.37
The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice. Postgrad Med J (1998) 1.37
Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med (1994) 1.37
Arterial closure devices. A review. J Cardiovasc Surg (Torino) (2007) 1.34
Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet (1986) 1.32
Sodium is more important than calcium in essential hypertension. Hypertension (1985) 1.26
Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure. BMJ (1990) 1.21
Structural skin capillary rarefaction in essential hypertension. Hypertension (1999) 1.21
Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin. J Hypertens (1985) 1.21
Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. Br Med J (Clin Res Ed) (1982) 1.18
Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart (2003) 1.16
Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension (1999) 1.15
Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension (1998) 1.15
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Br Med J (1979) 1.14
Hyperthyroidism and a parathyroid adenoma complicating lithium treatment. Lancet (1977) 1.12
The role of transradial diagnostic angiography. Cardiovasc Intervent Radiol (1997) 1.11
Arteriovenous malformation of the uterus associated with secondary postpartum hemorrhage. Ultrasound Obstet Gynecol (2003) 1.09
Dietary salt and blood pressure. Lancet (1994) 1.08
Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man. Br J Clin Pharmacol (1976) 1.08
Endovascular repair of iliac artery injury complicating lumbar disc surgery. Eur Spine J (2007) 1.07
Clinical outcome and restenosis following percutaneous transluminal angioplasty for ischaemic rest pain or ulceration. Br J Surg (1995) 1.06
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J (Clin Res Ed) (1987) 1.04
Effect of salt intake on renal excretion of water in humans. Hypertension (2001) 1.04
Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci (Lond) (1999) 1.04
Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens (1993) 1.04
Effect of sodium intake on ability of human plasma to inhibit renal Na+-K+-adenosine triphosphatase in vitro. Lancet (1981) 1.02
The complications of high brachial artery puncture. Clin Radiol (1990) 1.01
Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens (1995) 1.01
Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Br Med J (Clin Res Ed) (1985) 1.01
A randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension. J Hypertens (1988) 1.01
Diuretics and oedema: how to avoid rebound sodium retention. Lancet (1992) 1.00
A family with autosomal dominant polycystic kidney disease not linked to chromosome 16p13.3. Clin Genet (1993) 1.00
The endovascular management of blue finger syndrome. Eur J Vasc Endovasc Surg (1999) 0.99
Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects. J Cardiovasc Pharmacol (1982) 0.99
Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol (1985) 0.98
Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J (Clin Res Ed) (1981) 0.98
Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) (1985) 0.98
Physiology: cardiac peptides and the control of sodium excretion. Nature (1984) 0.97
Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens (1996) 0.97
Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med (1991) 0.96
Dietary sodium and potassium intake and blood pressure. Lancet (1983) 0.96
Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens (1991) 0.95
Letter: Saralasin bolus test. Lancet (1975) 0.95
Sodium and blood pressure. Curr Opin Cardiol (2002) 0.95
The natriuretic hormone and essential hypertension. Lancet (1982) 0.94
Transepithelial sodium absorption is increased in people of African origin. Hypertension (2001) 0.94
Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension (1995) 0.94
Interested in developing a national programme to reduce dietary salt? J Hum Hypertens (2011) 0.93
The acute response to nifedipine is related to pre-treatment blood pressure. Postgrad Med J (1983) 0.93
Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension (2001) 0.92
Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.92
Phenformin and metabolic acidosis. Lancet (1972) 0.92
Cognitive impairment and white matter damage in hypertension: a pilot study. Acta Neurol Scand (2008) 0.91
Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy. Am J Cardiol (1991) 0.91
Harmful effects of dietary salt in addition to hypertension. J Hum Hypertens (2002) 0.91
Azathioprine for myasthenia gravis. Lancet (1972) 0.91
Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci (Lond) (1992) 0.91
Plasma atrial natriuretic peptide: its relationship to changes in sodium intake, plasma renin activity and aldosterone in man. Clin Sci (Lond) (1987) 0.90
Letter: Hypotension during angiotensin blockade with saralasin. Lancet (1975) 0.90
Dietary sodium and blood pressure. JAMA (1996) 0.89
Staphylococcus lugdunensis endocarditis following cardiac catheterisation. Int J Cardiol (2007) 0.89
"Apparent" heart failure: a syndrome caused by renal artery stenoses. Heart (2000) 0.89